Reducing the airborne transmission risk for SARS-CoV-2 – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Nov 6 2020

Rapid Reviews: COVID-19 (RR:C19), an open-access overlay journal published by the MIT Press that accelerates peer review of is currently soliciting reviews of the following COVID-19 preprints. COVID-19-related research preprints,

These preprints have been selected for review because they have the potential to enhance our understanding of SARS-CoV-2 or have been flagged as potentially misleading. Preprints with two finished reviews should be published within 10-14 days. Additional information or early access to these peer-reviews is available upon request.

This preprint estimates that the use of air purifiers in school classrooms can reduce an inhaled dose of COVID-19 by a factor of six. Will be useful to parents and school districts planning how to safely reopen schools.

Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon regimens have been touted as potential therapeutics for COVID-19 patients, but this preprint finds they have little to no effects on overall mortality, initiation of ventilation, or duration of hospital stay. This research has the potential to directly impact point of care decisions.

This preprint shows that universal mask mandates could reduce deaths by 815,600 globally before the year's end. It adds to the growing science showing masks are an effective tool in fighting the spread of COVID-19.

This large cross-sectional study explores how socioeconomics and race affect COVID-19 mortality. Its findings could lead to a more detailed understanding of the specific processes that result in health inequities.

This research explores whether previous infections with seasonal coronaviruses protects against a severe COVID-19 disease course. This immunological cross-reactivity has important implications on vaccine strategies.

Posted in: Healthcare News

Tags: ACE2, Androgen, Antibodies, Antigen, Blood, Brain, Drugs, Education, Electronic Health Record, Fertility, Genes, Glycoprotein, Heparin, Hospital, Hydroxychloroquine, Immunoassay, Influenza, Kidney, Lopinavir, Machine Learning, Mesenchymal Stem Cells, Methanol, Mortality, Pandemic, Phenotype, Placebo, Poverty, Public Health, Remdesivir, Research, SARS-CoV-2, Stem Cells, therapeutics, Thrombosis, Umbilical Cord, Vaccine, Virus

See original here:

Reducing the airborne transmission risk for SARS-CoV-2 - News-Medical.Net